Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: Cost effectiveness analysis

BMJ

Volumn 316, Issue 7142, 1998, Pages 1417-1422

  Tynell, Elsa ^a   Andersson, Soren ^b   Lithander, Eva ^c   Arneborn, Malin ^b   Blomberg, Jonas ^d   Hansson, Hans Bertil ^e   Krook, Aud ^f   Nomberg, Mats ^g   Ramstedt, Kristina ^b   Shanwell, Agneta ^g   Bjorkman, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g South Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; COST EFFECTIVENESS ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; IMMUNOBLOTTING; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SWEDEN; VIRUS INFECTION;

ADULT; BLOOD DONORS; BLOOD TRANSFUSION; BLOTTING, WESTERN; COST-BENEFIT ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INCIDENCE; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MASS SCREENING; MODELS, ECONOMIC; PREVALENCE; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN;

EID: 18144437442     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.316.7142.1417     Document Type: Article

References (29)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell Iymphoma. Proc Natl Acad Sci U S A 1980; 77: 7415-7419.
2. Kalyanaraman VS, Sarngadharan MG, Robert-Gurhoff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV II) associated with a T-cell variant of hairy cell leukemia. Science 1982; 218: 571-573.
3. Anonymous. Licensure of screening tests for antibody to human T-lymphotropic virus type-I. MMWR Morb Mortal Wkly Rep 1988; 37: 736-740, 745-7.
4. Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells. Ann Neurol 1987; 21: 117-122.
5. Yamaguchi K. Human T-lymphotropic virus type I in Japan. Lancet 1994; 343: 213-216.
6. Iwata K, Ito S, Saito H, Ito M, Nagatomo M, Yamasaki T, et al. Mortality among inhabitants of an HTLV-I endemic area in Japan. Jpn J Cancer Res 1994; 85: 231-237.
7. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Hideyuki N, Okochi K. Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis 1986; 154: 851-857.
8. Tajima K, Takezaki T, Ito M, Ito S, Kinoshita K. Short term breastfeeding may reduce the risk of vertical transmission of HTLV-I. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 285.
9. Nyambi P, Ville Y, Louwagie J, Bedjabaga E, Glowaczower M, Peters M, et al. Mother to child transmission of human T-cell lymphotropic virus type I and II in Gabon. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 258.
10. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984; 46: 245-253.
11. Kamihira S, Nakasima S, Oyakawa Y, Moriuti Y, Ichimaru M, Okuda H, et al. Transmission of human T cell lymphotropic virus type I by blood transfusion before and after mass screening of sera from seropositive donors. Vox Sang 1987; 52: 43-44.
12. Anonymous. Virus diseases—human T-cell lymphotropic virus-I. WHO Wkly Epidemiological Rec 1992; 29: 213-216.
13. The HTLV European research network. Seroepidemiology of the human T-cell leukemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 68-77.
14. Krook A, Albert J, Andersson S, Biberfeld G, Blomberg J, Eklund J, et al. Prevalence and risk factors for human T-cell lymphoma virus type II infection among 913 injecting drug users in Stockholm 1994. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 381-386.
15. Sullivan M, Williams A, Fang C, Grandinetti T, Poiesz B, Ehrlich G. Transmission of human T-lymphotropic virus types I and II by blood transfusion. Arch Intern Med 1991; 151: 2043-2048.
16. Donegan E, Lee H, Operkalski EA, Shaw GM, Kleinman SH, Busch MP, et al. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type I. Transfusion 1994; 34: 478-483.
17. Bohn-Christansen C. Experience with one year of blood donor screening for HTLV I/II in Denmark. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 251.
18. Zaaijer HL, Cuypers HTM, Dudok de Wit C, Lelie PN. Results of 1 year screening of donors in the Netherlands for human T lymphotropic virus (HTLV) type I: significance of western blot patterns for confirmation of HTLV infection. Transfusion 1994; 34: 1-4.
19. Brennan M, Runganga J, Barbara JAJ, Contreras M, Tedder RS, Garson JA, et al. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. BMJ 1993; 307: 1235-1239.
20. Couroucé AM, Pillonel J, Lemaire JM, Maniez M, Brunet JB. Seroepidemiology of HTLV I/II in universal screening of blood donations in France. AIDS 1993; 7: 841-847.
21. Pillonel J, Couroucé AM, Lemaire JM. HTLV-I/II among French blood donors. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 251.
22. Lee HH, Swanson P, Rosenblatt JD, Chen J, Sherwood W, Smith D, et al. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991; 337: 1435-1439.
23. Andersson S, Godoy K, Thorstensson R, Dias F, Biberfeld G. Evaluation of immunoassays for detection of HTLV I/II antibodies. In: Programme and abstracts of the 10th international conference on AIDS/STD, Yokohama Japan 7-12 August 1994. Abstract No PA 151.
24. Defer C, Coste J, Deschamps S, Voisin S, Lemaire J-M, Maniez M, et al. Contribution of polymerase chain reaction and radioimmunoprecipitation assay in the confirmation of human T-lymphotropic virus infection in French blood donors. Transfusion 1995; 35: 506-600.
25. Kwok S, Lipka JJ, McKinney N, Kellogg DE, Poiesz B, Foung SKH, et al. Low incidence of HTLV infections in random blood donors with indeterminate western blot patterns. Transfusion 1990; 30: 491-493.
26. Murphy E. The epidemiology of HTLV-I: modes of transmission and their relation to patterns of seroprevalence. In: Blattner WA, ed. Human retrovirology: HTLV., New York: Raven Press, 1990: 290-290.
27. Dalgleish A. Human T cell leukaemia/lymphoma virus and blood donation. BMJ 1993; 307: 1224-1225.
28. Kågeson P. Getting the prices right: A European scheme for making transport pay its true costs., Brussels: European Federation for Transport and Environment, 1993: 114.
29. The cost of living. Economist, 1966 Mar 16: 29.